66 results
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
14 Jun 24
Report of Foreign Private Issuer
7:26am
UMG Head of Department Covering discovery and initial characterization of NanoAbs aimed at predefined list of molecular targets. Designed to create … disease) ▪ Individual preferences Credit: Prof. Michael P. Schön, Department of Dermatology, Venereology and Allergology Lower Saxony Institute
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
13 Jun 24
Report of Foreign Private Issuer
10:16am
the Listing Qualification Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) that the Company has regained compliance with the minimum
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
28 May 24
Report of Foreign Private Issuer
2:14pm
Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, due to the Company’s non-compliance
6-K
EX-99.1
SCNI
Scinai Immunotherapeutics Ltd
7 May 24
Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal
10:24am
, 2024 from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, due
6-K
EX-99.1
0636m
25 Apr 24
Report of Foreign Private Issuer
4:00pm
6-K
EX-99.1
dgbmcorkwno9 905
16 Apr 24
Report of Foreign Private Issuer
5:27pm
6-K
EX-99.1
6fw72hie3v5kq ic
18 Jan 24
Report of Foreign Private Issuer
11:50am
6-K
EX-99.1
psf 1l9nj8j
9 Jan 24
Report of Foreign Private Issuer
8:45am
6-K
EX-1.1
2mm3sk7zip hjin8s
19 Sep 23
Report of Foreign Private Issuer
3:06pm
6-K
EX-99.1
grk z6qal10ih
23 Aug 23
Report of Foreign Private Issuer
6:10am
6-K
EX-99.1
7nsck qi3hfj
5 Jul 23
Report of Foreign Private Issuer
9:28am
8-K
EX-99.1
u0d n3o7lx
4 May 23
Regulation FD Disclosure
9:25am
8-K
xds0p bi321
4 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
10-K
fnzht
17 Apr 23
Annual report
4:06pm
6-K
EX-99.1
d8he156qtj194l
29 Dec 22
Report of Foreign Private Issuer
10:39am
6-K
EX-1.1
fko1hknb rhnpkvi
20 Dec 22
BiondVax Announces Closing of $8 Million Underwritten Public Offering
5:29pm
F-1/A
EX-1.1
5qwyha0i95
14 Dec 22
Registration statement (foreign) (amended)
4:45pm
F-1/A
EX-10.14
c6kttsfdpyftfl5w146
14 Dec 22
Registration statement (foreign) (amended)
4:45pm
6-K
EX-99.1
smnl 9blhhsea
10 Nov 22
Current Report
5:28pm